Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)
Ptc Therapeutics (PTCT) posted quarterly Current Taxes of $4.7 million for Q4 2025, down 0.51% year-over-year from $4.7 million in Q4 2024, and up 59.79% quarter-over-quarter from $2.9 million in Q3 2025.
Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025) Analysis & Trends
Ptc Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $4.7 million for Q4 2025.
- In Q4 2025, Current Taxes fell 0.51% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (down 0.51% YoY), while the FY2025 annual figure was $4.7 million, down 0.51% from the prior year.
- Current Taxes for Q4 2025 stood at $4.7 million, up from $2.9 million in the prior quarter.
- The five-year high for Current Taxes was $64.6 million in Q1 2025, with the low at $618000.0 in Q2 2021.
- The 5-year median for Current Taxes is $4.7 million (2025), against an average of $10.0 million.
- The sharpest annual moves came in 2021 and 2025: Current Taxes sank 70.17% in 2021, then surged 3425.48% in 2025.
- Ptc Therapeutics' Current Taxes stood at $1.3 million in 2021, then soared by 266.12% to $4.7 million in 2022, then slumped by 40.11% to $2.8 million in 2023, then jumped by 66.58% to $4.7 million in 2024, then declined by 0.51% to $4.7 million in 2025.
- Business Quant data shows PTCT's Current Taxes at $4.7 million in Q4 2025, $2.9 million in Q3 2025, and $39.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.68 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 39.92 Mn |
| Mar 31, 2025 | 64.62 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 11.15 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Jun 30, 2022 | 7.58 Mn |
| Mar 31, 2022 | 4.55 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Jun 30, 2021 | 618,000.00 |
| Mar 31, 2021 | 3.91 Mn |
| Dec 31, 2020 | 4.32 Mn |
| Sep 30, 2020 | 21.48 Mn |
| Dec 31, 2019 | 499,000.00 |